financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lifts Opinion On Mccormick & Company, Incorporated To Buy From Hold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lifts Opinion On Mccormick & Company, Incorporated To Buy From Hold
Mar 26, 2024 8:35 AM

11:05 AM EDT, 03/26/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target by $12 to $85, 27x our FY 25 (Nov.) EPS of $3.16 (up from $2.96; FY 24 up to $2.88 from $2.81) vs. the 30x five-year average forward P/E. FQ1 (Feb-Q) adj-EPS of $0.63 (+7% Y/Y) beat by $0.06 on revenues of $1,603M (+2% Y/Y), $51M above consensus. MKC saw a sequential improvement in volume sales (-1% Y/Y vs. -3% Y/Y in FQ4), which we expect will continue this year, especially if MKC regains some of the lost distribution it experienced over the last few years. MKC is also investing in marketing and innovation and looking to narrow price gaps to store brands. Gross margins grew 140 bps Y/Y to 37.4%, but due to SG&A de-leverage (from higher marketing), operating margins only grew 30 bps Y/Y to 14.8%. We should see stronger margins in F2H 24. MKC kept its guidance unchanged, but will likely raise it next quarter, in our opinion. We believe MKC is on track to return to double-digit EPS growth next fiscal year (FY 25), as this fiscal year (FY 24) is expected to be a heavy investment year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Retains Buy Opinion On Shares Of Amgen Inc.
Research Alert: CFRA Retains Buy Opinion On Shares Of Amgen Inc.
May 3, 2024
10:00 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Amgen ( AMGN ) reported Q1 earnings yesterday after market close. We lift our target price to $357 from $352, 16.8x our 2025 EPS, slightly above AMGN's historical forward P/E...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Coinbase Global, Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Coinbase Global, Inc.
May 3, 2024
09:55 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our price target by $39 to $234 on EV/sales of 13.0x our 2024 sales estimate. We raise our 2024 EPS estimate by $5.05 to $7.60 and 2025's by...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Federal Realty Investment Trust
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Federal Realty Investment Trust
May 3, 2024
10:05 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our price target at $119, using a forward P/FFO of 17.5x our 2024 FFO estimate, a premium to retail REIT peers (12.3x) due to FRT's best-in-class portfolio of...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cbre Group, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cbre Group, Inc.
May 3, 2024
10:25 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target by $10 to $86, applying a forward P/E of 20.0x our 2024 EPS estimate, a premium to CBRE's ( CBRE ) 10-year average multiple of 16.5x...
Copyright 2023-2026 - www.financetom.com All Rights Reserved